Shock

Definition

Classification

1. Hypovolemic Shock

• Cause: Loss of blood or plasma volume (hemorrhage, burns, vomiting, diarrhea, trauma)
• Mechanism: Low cardiac output (CO) due to inadequate intravascular volume
• Features: Cool, clammy skin; tachycardia; hypotension; oliguria

2. Cardiogenic Shock

• Cause: Myocardial infarction, ventricular arrhythmia, cardiac tamponade, pulmonary embolism, ventricular rupture
• Mechanism: Failure of myocardial pump - intrinsic damage, extrinsic compression, or outflow obstruction leading to low CO
• Features: Similar to hypovolemic but with signs of pulmonary congestion (JVD, crackles)

3. Distributive / Septic Shock

• Cause: Overwhelming bacterial (gram-positive > gram-negative), fungal, or viral infections
• Mechanism: Massive activation of cytokine cascades -> peripheral vasodilation -> maldistribution of blood flow -> tissue hypoperfusion despite normal or high CO
• Features: Early: warm, flushed skin ("warm shock"); Late: cool, clammy

4. Obstructive Shock

• Cause: Tension pneumothorax, pulmonary embolism, cardiac tamponade
• Mechanism: Mechanical obstruction to flow - distinct from cardiogenic in that the myocardium itself is intact

5. Neurogenic Shock

• Cause: Spinal cord injury, anesthesia
• Mechanism: Loss of sympathetic vascular tone -> acute vasodilation -> hypotension and tissue hypoperfusion

Anaphylactic Shock

• IgE-mediated hypersensitivity reaction causing systemic vasodilation and increased vascular permeability

Pathophysiology

Cellular Level

• Aerobic respiration shifts to anaerobic glycolysis
• Lactate accumulates and diffuses into the blood
• ATP generation falls, causing failure of ion pumps and cellular swelling
• At a threshold, an irreversible cascade of intracellular events leads to cell death

Septic Shock Pathogenesis (most complex)

1. Inflammatory & counter-inflammatory responses: Microbial PAMPs and DAMPs engage TLRs, G-protein receptors, and C-type lectin receptors on innate immune cells. This activates NF-kB -> cytokine storm (TNF, IL-1, IL-12, IL-18, IFN-γ, HMGB1). Paradoxically, counter-regulatory immunosuppression (Th1 -> Th2 shift, IL-10, lymphocyte apoptosis) coexists, so patients oscillate between hyperinflammatory and immunosuppressed states.
2. Endothelial activation and injury: Cytokines loosen tight junctions -> protein-rich edema throughout the body. Activated endothelium upregulates NO and other vasodilators (C3a, C5a, PAF) -> systemic hypotension. Microvascular dysfunction leads to oxygen delivery-demand mismatch.
3. Procoagulant state: Cytokines increase tissue factor on monocytes, decrease endothelial anticoagulants (thrombomodulin, protein C, TFPI), and raise PAI-1 -> systemic thrombin activation -> DIC in up to 50% of patients. Fibrin-rich thrombi in small vessels further impair tissue perfusion.
4. Metabolic abnormalities: Insulin resistance and hyperglycemia (TNF, IL-1, catecholamines drive gluconeogenesis while suppressing insulin release and GLUT-4 expression). Functional adrenal insufficiency may develop (or frank Waterhouse-Friderichsen syndrome from DIC). Lactic acidosis from mitochondrial dysfunction.
5. Organ dysfunction: Hypotension + edema + microvascular dysfunction + thrombi -> multi-organ failure (kidneys, liver, lungs, heart). ARDS ("shock lung") from diffuse alveolar damage is a classic complication.

Stages of Shock (Hypovolemic / Cardiogenic Model)

Stage 1 - Nonprogressive (Compensated)

• Baroreceptor reflexes
• Catecholamine release (tachycardia, peripheral vasoconstriction)
• ADH release (fluid conservation)
• RAAS activation (renin-angiotensin-aldosterone)
• Coronary and cerebral vessels are relatively protected; blood is shunted away from skin/viscera
• Patient may appear "shocked" (pale, cool, diaphoretic) but BP may be normal

Stage 2 - Progressive (Decompensated)

• Widespread tissue hypoxia -> lactic acidosis
• Acidosis blunts arteriolar vasomotor response -> microvascular dilation and blood pooling
• Endothelial ischemic injury -> DIC risk
• Vital organ dysfunction begins to manifest

Stage 3 - Irreversible

• Lysosomal enzyme leakage aggravates cell injury
• Myocardial contractility further worsens
• Intestinal barrier breaks down -> gut flora enter circulation -> superimposed bacteremic shock
• Renal failure from ischemic injury
• Death follows despite intervention

Diagnosis

• Shock can occur with normal BP (compensated phase)
• Not all hypotension = shock
• Lactate >4 mmol/L or base deficit <-4 mEq/L warrants presumptive diagnosis
• Urine output <0.5 mL/kg/h = severe renal hypoperfusion
• Trending lactate and base deficit reliably gauge resuscitation adequacy

Morphological Consequences (Organ Pathology)

• Kidneys: Ischemic acute tubular necrosis (ATN) - most common reversible complication; fibrin thrombi in glomeruli
• Brain: Ischemic encephalopathy, selective neuronal necrosis
• Heart: Subendocardial ischemia/necrosis (watershed zone)
• Adrenals: Cortical cell lipid depletion (increased steroid synthesis under stress); frank necrosis (Waterhouse-Friderichsen syndrome) in DIC
• Lungs: "Shock lung" (ARDS/diffuse alveolar damage) - especially in septic or traumatic shock; lungs are relatively resistant in pure hypovolemic shock
• GI tract: Hemorrhagic enteropathy, mucosal necrosis
• Liver: Centrilobular necrosis (ischemic hepatitis)

Management

General Principles

• Identify and treat the underlying cause simultaneously with resuscitation
• Continuously monitor HR, BP, SpO2, urine output, lactate, base deficit
• Goal: restore tissue oxygenation and substrate delivery

Hemorrhagic Shock

• Ensure adequate ventilation/oxygenation
• Immediate hemorrhage control (pressure, traction, REBOA, surgical consultation)
• Judicious isotonic crystalloid (10-20 mL/kg) initially
• Balanced transfusion: PRBCs + fresh frozen plasma + platelets in massive hemorrhage (1:1:1 ratio)
• Treat dysrhythmias

Septic Shock (Sepsis-3 definition: sepsis + vasopressors required + lactate >2 mmol/L)

• Ensure oxygenation; reduce work of breathing
• 30 mL/kg crystalloid fluid challenge; titrate to dynamic indices and urine output
• Broad-spectrum antimicrobials early (within 1 hour); source control (drainage, debridement)
• Transfuse PRBCs if Hgb <7 g/dL
• If fluids fail to restore perfusion: vasopressors (norepinephrine is first-line)
• Consider low-dose corticosteroids for refractory shock

Cardiogenic Shock

• O2 and PEEP for pulmonary edema
• Norepinephrine (0.5 mcg/min) + dobutamine (5 mcg/kg/min) empirically
• Reverse the underlying cause (PCI, thrombolysis)
• Intra-aortic balloon pump (IABP) for refractory cases
• Consider mechanical circulatory support (Impella, ECMO)

Recent Evidence (2024-2026)

• Prolonged vs intermittent beta-lactam infusions in septic shock (JAMA 2024, PMID 38864162): Systematic review/meta-analysis showing prolonged infusion of beta-lactams improves clinical cure in adults with sepsis or septic shock.
• Methylene blue in septic shock (Crit Care Explor 2024, PMID 38904978): Systematic review/meta-analysis evaluating methylene blue as an adjunct vasopressor in refractory vasodilatory shock.

Quick Summary Table